246 related articles for article (PubMed ID: 20962663)
1. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials.
Iovieno N; Tedeschini E; Ameral VE; Rigatelli M; Papakostas GI
Int Clin Psychopharmacol; 2011 Mar; 26(2):69-74. PubMed ID: 20962663
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
[TBL] [Abstract][Full Text] [Related]
3. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
[TBL] [Abstract][Full Text] [Related]
6. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis.
Pedrelli P; Iovieno N; Vitali M; Tedeschini E; Bentley KH; Papakostas GI
J Clin Psychopharmacol; 2011 Oct; 31(5):582-6. PubMed ID: 21869696
[TBL] [Abstract][Full Text] [Related]
7. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
[TBL] [Abstract][Full Text] [Related]
8. Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis.
Tedeschini E; Fava M; Goodness TM; Papakostas GI
Eur Neuropsychopharmacol; 2010 Aug; 20(8):562-7. PubMed ID: 20219330
[TBL] [Abstract][Full Text] [Related]
9. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
Iovieno N; Papakostas GI
J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
[TBL] [Abstract][Full Text] [Related]
10. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
Iovieno N; Papakostas GI
J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
[TBL] [Abstract][Full Text] [Related]
11. Suicide rates in short-term randomized controlled trials of newer antidepressants.
Hammad TA; Laughren TP; Racoosin JA
J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
Levkovitz Y; Tedeschini E; Papakostas GI
J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of placebo rates in major depressive disorder trials.
Stolk P; Ten Berg MJ; Hemels ME; Einarson TR
Ann Pharmacother; 2003 Dec; 37(12):1891-9. PubMed ID: 14632596
[TBL] [Abstract][Full Text] [Related]
14. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
Nelson JC
Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach.
Tedeschini E; Fava M; Papakostas GI
J Clin Psychiatry; 2011 Jan; 72(1):98-113. PubMed ID: 21208576
[TBL] [Abstract][Full Text] [Related]
16. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
[TBL] [Abstract][Full Text] [Related]
17. Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
Kornstein SG; Jiang Q; Reddy S; Musgnung JJ; Guico-Pabia CJ
J Clin Psychiatry; 2010 Aug; 71(8):1088-96. PubMed ID: 20797382
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods.
Girardi P; Pompili M; Innamorati M; Mancini M; Serafini G; Mazzarini L; Del Casale A; Tatarelli R; Baldessarini RJ
Hum Psychopharmacol; 2009 Apr; 24(3):177-90. PubMed ID: 19229839
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant dose reduction and the risk of relapse in major depressive disorder.
Papakostas GI; Perlis RH; Seifert C; Fava M
Psychother Psychosom; 2007; 76(5):266-70. PubMed ID: 17700046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
